Literatur

Autor(en) Titel Quelle Links
Jacobi G, Korinthenberg R, Rutkowski S Diagnostik der Hirntumoren. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft (in Zusammenarbeit der Gesellschaft für Neuropädiatrie und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2006    
Jaffe ES et al. World Health Organization classification of tumours. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon 2001    
Jaffe ES, Harris NL, Stein H, Isaacson PG Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008 Dec 1; 112: 4384    
Jaffe N, Bruland O S, Bielack S Pediatric and Adolescent Osteosarcoma. Cancer Treatment and Research Vol. 152 2010    
James RM, Kinsey SE The investigation and management of chronic neutropenia in children. Archives of disease in childhood 2006, 91: 852    
Janka-Schaub G, Stuehrk H, Kortuem B, Graubner U, Haas R, Göbel U, Jürgens H, Spaar H, Winkler K Bone marrow blast count at day 28 as the single most important prognostic factor in childhood acute lymphoblastic leukemia. Haematol Blood Transfus 1992, 34A92211, 233    
Janka-Schaub G Immunological factors and childhood leukaemias-pathophysiological and clinical perspectives. Anonymous Medizinische Forschung 1993, 183    
Janka-Schaub G, Gobrecht O, Gross S Dose intensity and prognosis in acute lymphocytic leukemia in childhood. Hämatol Blood Transf 1994, 36    
Janka-Schaub G, Harms D, Goebel U, Graubner U, Gutjahr P, Haas R, Jürgens H, Spaar H, Winkler K Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study Group. Eur J Pediatr 1996, 155: 640    
Janka-Schaub G, Harms D, Den Boer M, Veerman A, Pieters R In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97. Klin Pädiatr 1999, 211: 233    
Janoueix-Lerosey I, Penther D, Thioux M, de Cremoux P, Derre J, Ambros P, Vielh P, Benard J, Aurias A, Delattre O Molecular analysis of chromosome arm 17q gain in neuroblastoma. Genes Chromosomes Cancer 2000, 28: 276    
Jankovic M, Reciputo A, Haupt R, Micalizzi C, Manganini C, Frey E, Lackner H, Maurus R, Beck J, Langer T, Marx M, Krappmann P, Magyarosy E, Feldges A, Weel-Sipman M ELTEC. Med Pediatr Oncol 2002, 38    
Janßen K Chemische Umwelttoxikologie, in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 64    
Janka GE Familial and acquired hemophagocytic lymphohistiocytosis. European journal of pediatrics 2007, 166: 95    
Janka GE Hemophagocytic syndromes. Blood reviews 2007, 21: 245    
Janka GE Familial and acquired hemophagocytic lymphohistiocytosis. Annual review of medicine 2012, 63: 233    
Janka GE, Lehmberg K Hemophagocytic syndromes-an update. Blood reviews 2014, 28: 135    
Japp AS, Gessi M, Messing-Jünger M, Denkhaus D, Zur Mühlen A, Wolff JE, Hartung S, Kordes U, Klein-Hitpass L, Pietsch T High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors. Journal of neuropathology and experimental neurology 2015, 74: 110    
Jarrett RF Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leukemia & lymphoma 2003, 44 Suppl 3:S27    
Jenkin D, Goddard K, Armstrong D, Becker L, Berry M, Chan H, Doherty M, Greenberg M, Hendrick B, Hoffman H, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990, 19: 265    
Jensen M, Ernestus K, Kemshead J, Klehr M, Von Bergwelt-Baildon MS, Schinkothe T, Schultze JL, Berthold F The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis. Clinical and experimental immunology 2003, 134: 253    
Jensen M, Tawadros S, Sedlacek HH, Schultze JL, Berthold F NK cell depletion diminish tumour-specific B cell responses. Immunology letters 2004, 93(2-3): 205    
Jennings I, Perry D, Watson H, Alikhan R, Laffan M, Gomez K, Kitchen S, Walker I, Haemostasis and Thrombosis Task Force of the British Society for Haematology & UK NEQAS for Blood Coagulation Quality assurance and tests of platelet function. British journal of haematology 2018, 181: 560    
Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, Gandellini F, Stewart DM, Zhu Q, Nelson DL, Notarangelo LD, Ochs HD Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004 Dec 15; 104: 4010    
Johnson P, Glennie M The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 2003, 30 (Suppl 2): 3    
Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DT, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM, Kool M Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer cell 2016, 29: 379    
Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, Gronych J, Lasitschka B, Schmidt S, Seker-Cin H, Witt H, Sultan M, Ralser M, Northcott PA, Hovestadt V, Bender S, Pfaff E, Stark S, Faury D, Schwartzentruber J, Majewski J, Weber UD, Zapatka M, Raeder B, Schlesner M, Worth CL, Bartholomae CC, von Kalle C, Imbusch CD, Radomski S, Lawerenz C, van Sluis P, Koster J, Volckmann R, Versteeg R, Lehrach H, Monoranu C, Winkler B, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, Ebinger M, Schuhmann MU, Cho YJ, Pomeroy SL, von Deimling A, Witt O, Taylor MD, Wolf S, Karajannis MA, Eberhart CG, Scheurlen W, Hasselblatt M, Ligon KL, Kieran MW, Korbel JO, Yaspo ML, Brors B, Felsberg J, Reifenberger G, Collins VP, Jabado N, Eils R, Lichter P, Pfister SM, International Cancer Genome Consortium PedBrain Tumor Project Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 2013, 45: 927    
Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher MJ, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M, Mueller S, Perilongo G, Schouten van Meeteren AYN, Tabori U, Warren K, Waanders AJ, Walker D, Weiss W, Witt O, Wright K, Zhu Y, Bowers DC, Pfister SM, Packer RJ Pediatric low-grade gliomas: next biologically driven steps. Neuro-oncology 2018, 20: 160    
Jones DTW, Witt O, Pfister SM BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018, 36: 96    
Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL How I treat hemophagocytic lymphohistiocytosis. Blood 2011, 118: 4041    
Jost W H Diagnostik und Therapie von neurogenen Blasenstörungen - Leitlinien für Diagnostik und Therapie in der Neurologie. AWMF online 2015    
Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000, 15: 652    
Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Jürgens H, Craft A Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E. W.I. N.G. 99 clinical trial. Pediatric blood & cancer 2006, 47: 22    
Jünger ST, Mynarek M, Wohlers I, Dörner E, Mühlen AZ, Velez-Char N, von Hoff K, Rutkowski S, Warmuth-Metz M, Kortmann RD, Timmermann B, Rahmann S, Klein-Hitpass L, von Bueren AO, Pietsch T Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort. Acta neuropathologica communications 2019, 7: 181    
Juhnke BO, Mynarek M, Rutkowski S Refining medulloblastoma subgroups. The Lancet. Oncology 2017, 18: 847    
Jumaa H, Bossaller L, Portugal K, Storch B, Lotz M, Flemming A, Schrappe M, Postila V, Riikonen P, Pelkonen J, Niemeyer C, Reth M Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003, 423: 452    
Jung R, Jacobs U, Krumbholz M, Langer T, Keller T, De Lorenzo P, Valsecchi MG, van der Velden VH, Moericke A, Stanulla M, Teigler-Schlegel A, Panzer-Gruemayer ER, van Dongen JJ, Schrappe M, den Boer ML, Pieters R, Rascher W, Metzler M Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment. Leukemia 2010, 24: 903    
Junk S, Cario G, Wittner N, Stanulla M, Scherer R, Schlegelberger B, Schrappe M, von Neuhoff N, Lauten M Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines. Klin Pädiatr 2015, 227: 123    
Jung EW, Murphy ES, Jung DL, Chao ST, Suh JH Pediatric radiosurgery: A review. Appl Rad Oncol 2015    
Junk SV, Klein N, Schreek S, Zimmermann M, Moericke A, Bleckmann K, Alten J, Dagdan E, Cario G, Kratz CP, Schrappe M, Stanulla M TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia. Haematologica 2019, 104:e402-e405    
Jurklies C Das Retinoblastom - Diagnose und Therapie. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2007, 1: 26    
Jürgens H, Janka-Schaub G, Ibrahim M, Tonert C, Winkler K, Göbel U Prognostic significance of exposure to intermediate-dose Methotrexate in children with standard risk ALL:the COALL 82/85 experience. Hämatol Blood Transf 1992, 34: 238    
Jürgens H Interdisciplinary therapy of Ewing sarcoma. Schweiz Rundsch Med Prax 1995, 84: 1005    
Jürgens H, Ritter J Lungenmetastasen bei Malignomen im Kindesalter. Z Herz-Thorax-Gefäáchir 1996, 10: 9    
Jürgens H Recent advances in childhood cancer. Eur J Cancer 1997, 33: 15    
Juergens C, Weston C, Lewis I, Whelan J, Paulussen M, Oberlin O, Michon J, Zoubek A, Jürgens H, Craft A Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E. W.I. N.G. 99 clinical trial. Pediatric blood & cancer 2006, 47: 22    
Jürgens H, Paulussen M, Zoubek A Ewing-Tumoren, in: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer Verlag 2006, 894    
47 items found

Die Literatur-Datenbank ist alphabetisch nach dem Namen des Erstautors sortiert - bitte anklicken. Sie umfasst alle Angaben, die im Laufe der letzten Jahre von den Studienzentralen ausgewählt wurden oder die in diesem Informationsangebot referenziert werden, zum Beispiel in den Patienteninformationstexten.